The homeostatic role between exosomes and autophagy depends on the intracellular and intercellular crosstalk.
Their intracellular connections intersect through shared molecular machinery or organelle.
Exosomal miRNAs and proteins activate or inhibit autophagy-related signals to mediate intercellular crosstalk.
| [1] | K alluri R. and LeBleu V. S. (2020). The biology,function,and biomedical applications of exosomes. Science 367:eaau6977. DOI:10.1126/science.aau6977 |
| [2] | Harding C., Heuser J. and Stahl P. (1983). Receptor-mediated endocytosis of transferrin and recycling of the transferrin receptor in rat reticulocytes. J. Cell Biol. 97:329−339. DOI:10.1083/jcb.97.2.329 |
| [3] | Pan B. T. and Johnstone R. M. (1983). Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: selective externalization of the receptor. Cell 33:967−978. DOI:10.1016/0092-8674(83)90040-5 |
| [4] | Isaac R., Reis F. C. G., Ying W., et al. (2021). Exosomes as mediators of intercellular crosstalk in metabolism. Cell Metab. 33:1744−1762. DOI:10.1016/j.cmet.2021.08.006 |
| [5] | Klionsky D. J., Abdel-Aziz A. K., Abdelfatah S., et al. (2021). Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1. Autophagy 17:1−382. DOI:10.1080/15548627.2020.1797280 |
| [6] | Kuo I. Y., Hsieh C. H., Kuo W. T., et al. (2022). Recent advances in conventional and unconventional vesicular secretion pathways in the tumor microenvironment. J Biomed Sci 29:56. DOI:10.1186/s12929-022-00837-8 |
| [7] | De Duve C. and Wattiaux R. (1966). Functions of lysosomes. Annu. Rev. Physiol. 28:435−492. DOI:10.1146/annurev.ph.28.030166.002251 |
| [8] | Zeng X., Zhang Y. D., Ma R. Y., et al. (2022). Activated Drp1 regulates p62-mediated autophagic flux and aggravates inflammation in cerebral ischemia-reperfusion via the ROS-RIP1/RIP3-exosome axis. Mil. Med. Res. 9:25. DOI:10.1186/s40779-022-00383-2 |
| [9] | Hu S., Zhu M., Xing H., et al. (2024). Thread-structural microneedles loaded with engineered exosomes for annulus fibrosus repair by regulating mitophagy recovery and extracellular matrix homeostasis. Bioact. Mater. 37:1−13. DOI:10.1016/j.bioactmat.2024.03.006 |
| [10] | Albacete-Albacete L., Navarro-Lerida I., Lopez J. A., et al. (2020). ECM deposition is driven by caveolin-1-dependent regulation of exosomal biogenesis and cargo sorting. J. Cell Biol. 219:e202006178. DOI:10.1083/jcb.202006178 |
| [11] | Hubert M., Larsson E., Vegesna N. V. G., et al. (2020). Lipid accumulation controls the balance between surface connection and scission of caveolae. Elife 9:e55038. DOI:10.7554/eLife.55038 |
| [12] | Liese S., Wenzel E. M., Kjos I., et al. (2020). Protein crowding mediates membrane remodeling in upstream ESCRT-induced formation of intraluminal vesicles. Proc. Natl. Acad. Sci. USA 117:28614−28624. DOI:10.1073/pnas.2014228117 |
| [13] | Edgar J. R., Eden E. R. and Futter C. E. (2014). Hrs- and CD63-dependent competing mechanisms make different sized endosomal intraluminal vesicles. Traffic 15:197−211. DOI:10.1111/tra.12139 |
| [14] | Ferguson S. M. and De Camilli P. (2012). Dynamin, a membrane-remodelling GTPase. Nat Rev Mol. Cell Biol. 13:75−88. DOI:10.1038/nrm3266 |
| [15] | Vietri M., Radulovic M. and Stenmark H. (2020). The many functions of ESCRTs. Nat Rev Mol Cell Biol 21:25−42. DOI:10.1038/s41580-019-0177-4 |
| [16] | Kalluri R. (2016). The biology and function of exosomes in cancer. J. Clin. Invest. 126:1208−1215. DOI:10.1172/JCI81135 |
| [17] | van Niel G., D'Angelo G. and Raposo G. (2018). Shedding light on the cell biology of extracellular vesicles. Nat. Rev. Mol. Cell Biol. 19:213−228. DOI:10.1038/nrm.2017.125 |
| [18] | Mathieu M., Martin-Jaular L., Lavieu G., et al. (2019). Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication. Nat. Cell Biol. 21:9−17. DOI:10.1038/s41556-018-0250-9 |
| [19] | Arya S. B., Collie S. P. and Parent C. A. (2024). The ins-and-outs of exosome biogenesis, secretion, and internalization. Trends Cell Biol. 34:90−108. DOI:10.1016/j.tcb.2023.06.006 |
| [20] | Woodman P. G. and Futter C. E. (2008). Multivesicular bodies: co-ordinated progression to maturity. Curr. Opin. Cell Biol. 20:408−414. DOI:10.1016/j.ceb.2008.04.001 |
| [21] | Kahlert C. and Kalluri R. (2013). Exosomes in tumor microenvironment influence cancer progression and metastasis. J. Mol. Med. 91:431−437. DOI:10.1007/s00109-013-1020-6 |
| [22] | Wenzel E. M., Schultz S. W., Schink K. O., et al. (2018). Concerted ESCRT and clathrin recruitment waves define the timing and morphology of intraluminal vesicle formation. Nat. Commun. 9:2932. DOI:10.1038/s41467-018-05345-8 |
| [23] | Matsui T., Osaki F., Hiragi S., et al. (2021). ALIX and ceramide differentially control polarized small extracellular vesicle release from epithelial cells. EMBO Rep. 22:e51475. DOI:10.15252/embr.202051475 |
| [24] | Guo B. B., Bellingham S. A. and Hill A. F. (2015). The neutral sphingomyelinase pathway regulates packaging of the prion protein into exosomes. J. Biol. Chem. 290:3455−3467. DOI:10.1074/jbc.M114.605253 |
| [25] | Trajkovic K., Hsu C., Chiantia S., et al. (2008). Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 319:1244−1247. DOI:10.1126/science.1153124 |
| [26] | Ghossoub R., Lembo F., Rubio A., et al. (2014). Syntenin-ALIX exosome biogenesis and budding into multivesicular bodies are controlled by ARF6 and PLD2. Nat. Commun. 5:3477. DOI:10.1038/ncomms4477 |
| [27] | Wei D., Zhan W., Gao Y., et al. (2021). RAB31 marks and controls an ESCRT-independent exosome pathway. Cell Res. 31:157−177. DOI:10.1038/s41422-020-00409-1 |
| [28] | Sung B. H., von Lersner A., Guerrero J., et al. (2020). A live cell reporter of exosome secretion and uptake reveals pathfinding behavior of migrating cells. Nat Commun 11:2092. DOI:10.1038/s41467-020-15747-2 |
| [29] | Fan S. J., Kroeger B., Marie P. P., et al. (2020). Glutamine deprivation alters the origin and function of cancer cell exosomes. EMBO J. 39:e103009. DOI:10.15252/embj.2019103009 |
| [30] | Park S. J., Kim J. M., Kim J., et al. (2018). Molecular mechanisms of biogenesis of apoptotic exosome-like vesicles and their roles as damage-associated molecular patterns. Proc. Natl. Acad. Sci. USA 115:E11721−E11730. DOI:10.1073/pnas.1811432115 |
| [31] | Beillevaire D., Migneault F., Turgeon J., et al. (2022). Autolysosomes and caspase-3 control the biogenesis and release of immunogenic apoptotic exosomes. Cell Death Dis. 13:145. DOI:10.1038/s41419-022-04591-5 |
| [32] | Dieudé M., Bell C., Turgeon J., et al. (2015). The 20S proteasome core, active within apoptotic exosome-like vesicles, induces autoantibody production and accelerates rejection. Sci. Transl. Med. 7:318ra200. DOI:10.1126/scitranslmed.aac9816 |
| [33] | Afonso P. V., Janka-Junttila M., Lee Y. J., et al. (2012). LTB4 is a signal-relay molecule during neutrophil chemotaxis. Dev. Cell 22:1079−1091. DOI:10.1016/j.devcel.2012.02.003 |
| [34] | Majumdar R., Tavakoli Tameh A., Arya S. B., et al. (2021). Exosomes mediate LTB4 release during neutrophil chemotaxis. PLoS Biol. 19:e3001271. DOI:10.1371/journal.pbio.3001271 |
| [35] | Arya S. B., Chen S., Jordan-Javed F., et al. (2022). Ceramide-rich microdomains facilitate nuclear envelope budding for non-conventional exosome formation. Nat. Cell Biol. 24:1019−1028. DOI:10.1038/s41556-022-00934-8 |
| [36] | Li Q., Liu Q., Li S., et al. (2025). Golgi-derived extracellular vesicle production induced by SARS-CoV-2 envelope protein. Apoptosis 30:197−209. DOI:10.1007/s10495-024-02035-3 |
| [37] | Parzych K. R. and Klionsky D. J. (2014). An overview of autophagy: morphology, mechanism, and regulation. Antioxid Redox Signal 20:460−473. DOI:10.1089/ars.2013.5371 |
| [38] | Farré J. C. and Subramani S. (2004). Peroxisome turnover by micropexophagy: an autophagy-related process. Trends Cell Biol. 14:515−523. DOI:10.1016/j.tcb.2004.07.014 |
| [39] | Uttenweiler A. and Mayer A. (2008). Microautophagy in the yeast Saccharomyces cerevisiae. Methods Mol. Biol. 445:245−259. DOI:10.1007/978-1-59745-157-4_16 |
| [40] | Kaushik S. and Cuervo A. M. (2012). Chaperone-mediated autophagy: a unique way to enter the lysosome world. Trends Cell Biol. 22:407−417. DOI:10.1016/j.tcb.2012.05.006 |
| [41] | Galluzzi L., Baehrecke E. H., Ballabio A., et al. (2017). Molecular definitions of autophagy and related processes. Embo J. 36:1811−1836. DOI:10.15252/embj.201796697 |
| [42] | Lin M. G. and Hurley J. H. (2016). Structure and function of the ULK1 complex in autophagy. Curr. Opin. Cell Biol. 39:61−68. DOI:10.1016/j.ceb.2016.02.010 |
| [43] | Li X., He S. and Ma B. (2020). Autophagy and autophagy-related proteins in cancer. Mol. Cancer 19:12. DOI:10.1186/s12943-020-1138-4 |
| [44] | Kawamata T., Kamada Y., Kabeya Y., et al. (2008). Organization of the pre-autophagosomal structure responsible for autophagosome formation. Mol. Biol. Cell 19:2039−2050. DOI:10.1091/mbc.e07-10-1048 |
| [45] | Chan E. Y., Longatti A., McKnight N. C., et al. (2009). Kinase-inactivated ULK proteins inhibit autophagy via their conserved C-terminal domains using an Atg13-independent mechanism. Mol. Cell Biol. 29:157−171. DOI:10.1128/mcb.01082-08 |
| [46] | Karanasios E., Stapleton E., Manifava M., et al. (2013). Dynamic association of the ULK1 complex with omegasomes during autophagy induction. J. Cell Sci. 126:5224−5238. DOI:10.1242/jcs.132415 |
| [47] | Shang J. N., Yu C. G., Li R., et al. (2024). The nonautophagic functions of autophagy-related proteins. Autophagy 20:720−734. DOI:10.1080/15548627.2023.2254664 |
| [48] | Axe E. L., Walker S. A., Manifava M., et al. (2008). Autophagosome formation from membrane compartments enriched in phosphatidylinositol 3-phosphate and dynamically connected to the endoplasmic reticulum. J. Cell Biol. 182:685−701. DOI:10.1083/jcb.200803137 |
| [49] | Itakura E. and Mizushima N. (2010). Characterization of autophagosome formation site by a hierarchical analysis of mammalian Atg proteins. Autophagy 6:764−776. DOI:10.4161/auto.6.6.12709 |
| [50] | Hamasaki M., Furuta N., Matsuda A., et al. (2013). Autophagosomes form at ER-mitochondria contact sites. Nature 495:389−393. DOI:10.1038/nature11910 |
| [51] | Glick D., Barth S. and Macleod K. F. (2010). Autophagy: cellular and molecular mechanisms. J. Pathol. 221:3−12. DOI:10.1002/path.2697 |
| [52] | Kaur J. and Debnath J. (2015). Autophagy at the crossroads of catabolism and anabolism. Nat. Rev. Mol. Cell Biol. 16:461−472. DOI:10.1038/nrm4024 |
| [53] | Xiong J. (2015). Atg7 in development and disease: panacea or Pandora's Box. Protein Cell 6:722−734. DOI:10.1007/s13238-015-0195-8 |
| [54] | Yu J., Bao C., Dong Y., et al. (2015). Activation of autophagy in rat brain cells following focal cerebral ischemia reperfusion through enhanced expression of Atg1/pULK and LC3. Mol. Med. Rep. 12:3339−3344. DOI:10.3892/mmr.2015.3850 |
| [55] | Kaizuka T., Morishita H., Hama Y., et al. (2016). An autophagic flux probe that releases an internal control. Mol. Cell 64:835−849. DOI:10.1016/j.molcel.2016.09.037 |
| [56] | Mizushima N. (2007). Autophagy: process and function. Genes Dev. 21:2861−2873. DOI:10.1101/gad.1599207 |
| [57] | Wei Y., Liu M., Li X., et al. (2018). Origin of the Autophagosome Membrane in Mammals. Biomed. Res. Int. 2018:1012789. DOI:10.1155/2018/1012789 |
| [58] | Zhao Y. G., Codogno P. and Zhang H. (2021). Machinery, regulation and pathophysiological implications of autophagosome maturation. Nat. Rev. Mol. Cell Biol 22:733−750. DOI:10.1038/s41580-021-00392-4 |
| [59] | Wang X. and Shen K. (2024). New scissor for lysosome. The Innovation Life 2:100064. DOI:10.59717/j.xinn-life.2024.100064 |
| [60] | Itakura E., Kishi-Itakura C. and Mizushima N. (2012). The hairpin-type tail-anchored SNARE syntaxin 17 targets to autophagosomes for fusion with endosomes/lysosomes. Cell 151:1256−1269. DOI:10.1016/j.cell.2012.11.001 |
| [61] | Matsui T., Jiang P., Nakano S., et al. (2018). Autophagosomal YKT6 is required for fusion with lysosomes independently of syntaxin 17. J. Cell Biol. 217:2633−2645. DOI:10.1083/jcb.201712058 |
| [62] | Jahn R. and Scheller R. H. (2006). SNAREs--engines for membrane fusion. Nat. Rev. Mol. Cell Biol. 7:631-643. DOI:10.1038/nrm2002. |
| [63] | Stroupe C., Collins K. M., Fratti R. A., et al. (2006). Purification of active HOPS complex reveals its affinities for phosphoinositides and the SNARE Vam7p. Embo J. 25:1579−1589. DOI:10.1038/sj.emboj.7601051 |
| [64] | Jiang P., Nishimura T., Sakamaki Y., et al. (2014). The HOPS complex mediates autophagosome-lysosome fusion through interaction with syntaxin 17. Mol. Biol. Cell 25:1327−1337. DOI:10.1091/mbc.E13-08-0447 |
| [65] | Yu I. M. and Hughson F. M. (2010). Tethering factors as organizers of intracellular vesicular traffic. Annu. Rev. Cell Dev. Biol. 26:137−156. DOI:10.1146/annurev.cellbio.042308.113327 |
| [66] | Tian Y., Li Z., Hu W., et al. (2010). C. elegans screen identifies autophagy genes specific to multicellular organisms. Cell 141:1042-1055. DOI:10.1016/j.cell.2010.04.034. |
| [67] | Zhao H., Zhao Y. G., Wang X., et al. (2013). Mice deficient in Epg5 exhibit selective neuronal vulnerability to degeneration. J. Cell Biol. 200:731−741. DOI:10.1083/jcb.201211014 |
| [68] | Wang Z., Miao G., Xue X., et al. (2016). The Vici Syndrome Protein EPG5 Is a Rab7 Effector that Determines the Fusion Specificity of Autophagosomes with Late Endosomes/Lysosomes. Mol. Cell 63:781−795. DOI:10.1016/j.molcel.2016.08.021 |
| [69] | McEwan D. G., Popovic D., Gubas A., et al. (2015). PLEKHM1 regulates autophagosome-lysosome fusion through HOPS complex and LC3/GABARAP proteins. Mol. Cell 57:39−54. DOI:10.1016/j.molcel.2014.11.006 |
| [70] | Wetzel L., Blanchard S., Rama S., et al. (2020). TECPR1 promotes aggrephagy by direct recruitment of LC3C autophagosomes to lysosomes. Nat. Commun. 11:2993. DOI:10.1038/s41467-020-16689-5 |
| [71] | Chen D., Fan W., Lu Y., et al. (2012). A mammalian autophagosome maturation mechanism mediated by TECPR1 and the Atg12-Atg5 conjugate. Mol. Cell 45:629−641. DOI:10.1016/j.molcel.2011.12.036 |
| [72] | Yang Z., Huang J., Geng J., et al. (2006). Atg22 recycles amino acids to link the degradative and recycling functions of autophagy. Mol Biol Cell 17:5094−5104. DOI:10.1091/mbc.e06-06-0479 |
| [73] | Tooze S. A., Abada A. and Elazar Z. (2014). Endocytosis and autophagy: exploitation or cooperation. Cold Spring Harb. Perspect. Biol. 6:a018358. DOI:10.1101/cshperspect.a018358 |
| [74] | Xu J., Camfield R. and Gorski S. M. (2018). The interplay between exosomes and autophagy - partners in crime. J. Cell Sci. 131:jcs215210. DOI:10.1242/jcs.215210 |
| [75] | Xing H., Tan J., Miao Y., et al. (2021). Crosstalk between exosomes and autophagy: A review of molecular mechanisms and therapies. J. Cell Mol. Med. 25:2297−2308. DOI:10.1111/jcmm.16276 |
| [76] | Murrow L., Malhotra R. and Debnath J. (2015). ATG12-ATG3 interacts with Alix to promote basal autophagic flux and late endosome function. Nat Cell Biol. 17:300−310. DOI:10.1038/ncb3112 |
| [77] | Leidal A. M. and Debnath J. (2021). Emerging roles for the autophagy machinery in extracellular vesicle biogenesis and secretion. FASEB Bioadv. 3:377−386. DOI:10.1096/fba.2020-00138 |
| [78] | Lock R., Kenific C. M., Leidal A. M., et al. (2014). Autophagy-dependent production of secreted factors facilitates oncogenic RAS-driven invasion. Cancer Discov. 4:466−479. DOI:10.1158/2159-8290.Cd-13-0841 |
| [79] | DeSelm C. J., Miller B. C., Zou W., et al. (2011). Autophagy proteins regulate the secretory component of osteoclastic bone resorption. Dev. Cell 21:966−974. DOI:10.1016/j.devcel.2011.08.016 |
| [80] | Guo H., Chitiprolu M., Roncevic L., et al. (2017). Atg5 disassociates the V1V0-ATPase to promote exosome production and tumor metastasis independent of canonical macroautophagy. Dev. Cell 43:716−730.e7. DOI:10.1016/j.devcel.2017.11.018 |
| [81] | Bel S., Pendse M., Wang Y., et al. (2017). Paneth cells secrete lysozyme via secretory autophagy during bacterial infection of the intestine. Science 357:1047−1052. DOI:10.1126/science.aal4677 |
| [82] | Debnath J., Gammoh N. and Ryan K. M. (2023). Autophagy and autophagy-related pathways in cancer. Nat. Rev. Mol. Cell Biol. 24:560−575. DOI:10.1038/s41580-023-00585-z |
| [83] | Torisu T., Torisu K., Lee I. H., et al. (2013). Autophagy regulates endothelial cell processing, maturation and secretion of von Willebrand factor. Nat. Med. 19:1281−1287. DOI:10.1038/nm.3288 |
| [84] | Manjithaya R., Anjard C., Loomis W. F., et al. (2010). Unconventional secretion of Pichia pastoris Acb1 is dependent on GRASP protein, peroxisomal functions, and autophagosome formation. J. Cell Biol. 188:537−546. DOI:10.1083/jcb.200911149 |
| [85] | Deretic V., Jiang S. and Dupont N. (2012). Autophagy intersections with conventional and unconventional secretion in tissue development, remodeling and inflammation. Trends Cell Biol. 22:397−406. DOI:10.1016/j.tcb.2012.04.008 |
| [86] | Ponpuak M., Mandell M. A., Kimura T., et al. (2015). Secretory autophagy. Curr. Opin. Cell Biol. 35:106−116. DOI:10.1016/j.ceb.2015.04.016 |
| [87] | Eden E. R., White I. J. and Futter C. E. (2009). Down-regulation of epidermal growth factor receptor signalling within multivesicular bodies. Biochem. Soc. Trans. 37:173−177. DOI:10.1042/bst0370173 |
| [88] | Phillips M. J. and Voeltz G. K. (2016). Structure and function of ER membrane contact sites with other organelles. Nat. Rev. Mol. Cell Biol. 17:69−82. DOI:10.1038/nrm.2015.8 |
| [89] | Fader C. M., Sánchez D., Furlán M., et al. (2008). Induction of autophagy promotes fusion of multivesicular bodies with autophagic vacuoles in k562 cells. Traffic 9:230−250. DOI:10.1111/j.1600-0854.2007.00677.x |
| [90] | Herranz G., Aguilera P., Dávila S., et al. (2019). Protein kinase c δ regulates the depletion of actin at the immunological synapse required for polarized exosome secretion by T Cells. Front Immunol 10:851. DOI:10.3389/fimmu.2019.00851 |
| [91] | Villarroya-Beltri C., Baixauli F., Mittelbrunn M., et al. (2016). ISGylation controls exosome secretion by promoting lysosomal degradation of MVB proteins. Nat. Commun. 7:13588. DOI:10.1038/ncomms13588 |
| [92] | Savina A., Fader C. M., Damiani M. T., et al. (2005). Rab11 promotes docking and fusion of multivesicular bodies in a calcium-dependent manner. Traffic 6:131−143. DOI:10.1111/j.1600-0854.2004.00257.x |
| [93] | Walsh R. B., Dresselhaus E. C., Becalska A. N., et al. (2021). Opposing functions for retromer and Rab11 in extracellular vesicle traffic at presynaptic terminals. J. Cell Biol. 220:e202012034. DOI:10.1083/jcb.202012034 |
| [94] | Lauwers E., Wang Y. C., Gallardo R., et al. (2018). Hsp90 mediates membrane deformation and exosome release. Mol. Cell 71:689−702.e689. DOI:10.1016/j.molcel.2018.07.016 |
| [95] | Kwon S. H., Oh S., Nacke M., et al. (2016). Adaptor protein CD2AP and L-type lectin LMAN2 regulate exosome cargo protein trafficking through the Golgi complex. J. Biol. Chem. 291:25462−25475. DOI:10.1074/jbc.M116.729202 |
| [96] | Hsu C., Morohashi Y., Yoshimura S., et al. (2010). Regulation of exosome secretion by Rab35 and its GTPase-activating proteins TBC1D10A-C. J. Cell Biol. 189:223−232. DOI:10.1083/jcb.200911018 |
| [97] | Wu B., Liu D. A., Guan L., et al. (2023). Stiff matrix induces exosome secretion to promote tumour growth. Nat. Cell Biol. 25:415−424. DOI:10.1038/s41556-023-01092-1 |
| [98] | Matsui T., Sakamaki Y., Nakashima S., et al. (2022). Rab39 and its effector UACA regulate basolateral exosome release from polarized epithelial cells. Cell Rep. 39:110875. DOI:10.1016/j.celrep.2022.110875 |
| [99] | Ostrowski M., Carmo N. B., Krumeich S., et al. (2010). Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat. Cell Biol. 12:19-30; sup pp 1-13. DOI:10.1038/ncb2000. |
| [100] | Verweij F. J., Bebelman M. P., George A. E., et al. (2022). ER membrane contact sites support endosomal small GTPase conversion for exosome secretion. J. Cell Biol. 221:e202112032. DOI:10.1083/jcb.202112032 |
| [101] | Amaravadi R. K., Kimmelman A. C. and Debnath J. (2019). Targeting autophagy in cancer: recent advances and future directions. Cancer Discov. 9:1167−1181. DOI:10.1158/2159-8290.Cd-19-0292 |
| [102] | Solvik T. A., Nguyen T. A., Tony Lin Y. H., et al. (2022). Secretory autophagy maintains proteostasis upon lysosome inhibition. J. Cell Biol. 221:e202110151. DOI:10.1083/jcb.202110151 |
| [103] | Sagini K., Buratta S., Delo F., et al. (2021). Drug-induced lysosomal impairment is associated with the release of extracellular vesicles carrying autophagy markers. Int. J. Mol. Sci. 22:12922. DOI:10.3390/ijms222312922 |
| [104] | Xu J., Yang K. C., Go N. E., et al. (2022). Chloroquine treatment induces secretion of autophagy-related proteins and inclusion of Atg8-family proteins in distinct extracellular vesicle populations. Autophagy 18:2547−2560. DOI:10.1080/15548627.2022.2039535 |
| [105] | Gordon P. B., Høyvik H. and Seglen P. O. (1992). Prelysosomal and lysosomal connections between autophagy and endocytosis. Biochem. J. 283 ( Pt 2):361-369. DOI:10.1042/bj2830361. |
| [106] | Liou W., Geuze H. J., Geelen M. J., et al. (1997). The autophagic and endocytic pathways converge at the nascent autophagic vacuoles. J. Cell Biol. 136:61−70. DOI:10.1083/jcb.136.1.61 |
| [107] | Chen Y. D., Fang Y. T., Cheng Y. L., et al. (2017). Exophagy of annexin A2 via RAB11, RAB8A and RAB27A in IFN-γ-stimulated lung epithelial cells. Sci. Rep. 7:5676. DOI:10.1038/s41598-017-06076-4 |
| [108] | Hurwitz S. N., Cheerathodi M. R., Nkosi D., et al. (2018). Tetraspanin CD63 bridges autophagic and endosomal processes to regulate exosomal secretion and intracellular signaling of Epstein-Barr virus LMP1. J. Virol. 92:e01969−17. DOI:10.1128/jvi.01969-17 |
| [109] | Wei X., Liang M., Deng M., et al. (2024). A switch from lysosomal degradation to secretory autophagy initiates osteogenic bone metastasis in prostate cancer. J. Extracell Vesicles 13:e70002. DOI:10.1002/jev2.70002 |
| [110] | Lauritzen I., Bini A., Bécot A., et al. (2025). Presenilins as hub proteins controlling the endocytic and autophagic pathways and small extracellular vesicle secretion. J. Extracell Vesicles 14:e70019. DOI:10.1002/jev2.70019 |
| [111] | Dupont N., Jiang S., Pilli M., et al. (2011). Autophagy-based unconventional secretory pathway for extracellular delivery of IL-1β. Embo J. 30:4701−4711. DOI:10.1038/emboj.2011.398 |
| [112] | Zhang M., Kenny S. J., Ge L., et al. (2015). Translocation of interleukin-1β into a vesicle intermediate in autophagy-mediated secretion. Elife 4:e11205. DOI:10.7554/eLife.11205 |
| [113] | Kimura T., Jia J., Kumar S., et al. (2017). Dedicated SNAREs and specialized TRIM cargo receptors mediate secretory autophagy. Embo J. 36:42−60. DOI:10.15252/embj.201695081 |
| [114] | Mathiassen S. G., De Zio D. and Cecconi F. (2017). Autophagy and the cell cycle: a complex landscape. Front. Oncol. 7:51. DOI:10.3389/fonc.2017.00051 |
| [115] | Lee I. H., Kawai Y., Fergusson M. M., et al. (2012). Atg7 modulates p53 activity to regulate cell cycle and survival during metabolic stress. Science 336:225−228. DOI:10.1126/science.1218395 |
| [116] | Long J. S., Kania E., McEwan D. G., et al. (2022). ATG7 is a haploinsufficient repressor of tumor progression and promoter of metastasis. Proc. Natl. Acad. Sci. USA 119:e2113465119. DOI:10.1073/pnas.2113465119 |
| [117] | Toda H., Mochizuki H., Flores R., 3rd, et al. (2008). Unc-51/ATG1 kinase regulates axonal transport by mediating motor-cargo assembly. Genes Dev. 22:3292−3307. DOI:10.1101/gad.1734608 |
| [118] | Mochizuki H., Toda H., Ando M., et al. (2011). Unc-51/ATG1 controls axonal and dendritic development via kinesin-mediated vesicle transport in the Drosophila brain. PLoS One 6:e19632. DOI:10.1371/journal.pone.0019632 |
| [119] | Shravage B. V., Hill J. H., Powers C. M., et al. (2013). Atg6 is required for multiple vesicle trafficking pathways and hematopoiesis in Drosophila. Development 140:1321−1329. DOI:10.1242/dev.089490 |
| [120] | Lőrincz P., Lakatos Z., Maruzs T., et al. (2014). Atg6/UVRAG/Vps34-containing lipid kinase complex is required for receptor downregulation through endolysosomal degradation and epithelial polarity during Drosophila wing development. Biomed. Res. Int. 2014:851349. DOI:10.1155/2014/851349 |
| [121] | Xiong Q., Ünal C., Matthias J., et al. (2015). The phenotypes of ATG9, ATG16 and ATG9/16 knock-out mutants imply autophagy-dependent and -independent functions. Open Biol. 5:150008. DOI:10.1098/rsob.150008 |
| [122] | Bader C. A., Shandala T., Ng Y. S., et al. (2015). Atg9 is required for intraluminal vesicles in amphisomes and autolysosomes. Biol. Open 4:1345−1355. DOI:10.1242/bio.013979 |
| [123] | Tan J. M. J., Mellouk N., Osborne S. E., et al. (2018). An ATG16L1-dependent pathway promotes plasma membrane repair and limits Listeria monocytogenes cell-to-cell spread. Nat. Microbiol. 3:1472−1485. DOI:10.1038/s41564-018-0293-5 |
| [124] | Tan J. M. J., Mellouk N. and Brumell J. H. (2019). An autophagy-independent role for ATG16L1: promoting lysosome-mediated plasma membrane repair. Autophagy 15:932−933. DOI:10.1080/15548627.2019.1586261 |
| [125] | Oh D. S. and Lee H. K. (2019). Autophagy protein ATG5 regulates CD36 expression and anti-tumor MHC class II antigen presentation in dendritic cells. Autophagy 15:2091−2106. DOI:10.1080/15548627.2019.1596493 |
| [126] | Galluzzi L. and Green D. R. (2019). Autophagy-independent functions of the autophagy machinery. Cell 177:1682−1699. DOI:10.1016/j.cell.2019.05.026 |
| [127] | Hawkins W. D. and Klionsky D. J. (2021). The expanding role of Atg8. Autophagy 17:3273−3274. DOI:10.1080/15548627.2021.1967566 |
| [128] | Cunha L. D., Yang M., Carter R., et al. (2018). LC3-associated phagocytosis in myeloid cells promotes tumor immune tolerance. Cell 175:429−441.e16. DOI:10.1016/j.cell.2018.08.061 |
| [129] | Jacquin E., Leclerc-Mercier S., Judon C., et al. (2017). Pharmacological modulators of autophagy activate a parallel noncanonical pathway driving unconventional LC3 lipidation. Autophagy 13:854−867. DOI:10.1080/15548627.2017.1287653 |
| [130] | Heckmann B. L., Teubner B. J. W., Tummers B., et al. (2019). LC3-associated endocytosis facilitates β-Amyloid clearance and mitigates neurodegeneration in murine Alzheimer's disease. Cell 178:536−551.e14. DOI:10.1016/j.cell.2019.05.056 |
| [131] | Leidal A. M., Huang H. H., Marsh T., et al. (2020). The LC3-conjugation machinery specifies the loading of RNA-binding proteins into extracellular vesicles. Nat. Cell Biol. 22:187−199. DOI:10.1038/s41556-019-0450-y |
| [132] | Liang C., Lee J. S., Inn K. S., et al. (2008). Beclin1-binding UVRAG targets the class C Vps complex to coordinate autophagosome maturation and endocytic trafficking. Nat. Cell Biol. 10:776−787. DOI:10.1038/ncb1740 |
| [133] | Kihara A., Noda T., Ishihara N., et al. (2001). Two distinct Vps34 phosphatidylinositol 3-kinase complexes function in autophagy and carboxypeptidase Y sorting in Saccharomyces cerevisiae. J. Cell Biol. 152:519−530. DOI:10.1083/jcb.152.3.519 |
| [134] | Liu J., Zhang Y., Liu A., et al. (2016). Distinct dasatinib-induced mechanisms of apoptotic response and exosome release in imatinib-resistant Human chronic myeloid leukemia cells. Int. J. Mol. Sci. 17:531. DOI:10.3390/ijms17040531 |
| [135] | Kriebel P. W., Majumdar R., Jenkins L. M., et al. (2018). Extracellular vesicles direct migration by synthesizing and releasing chemotactic signals. J. Cell Biol. 217:2891−2910. DOI:10.1083/jcb.201710170 |
| [136] | Qu Y., Franchi L., Nunez G., et al. (2007). Nonclassical IL-1beta secretion stimulated by P2X7 receptors is dependent on inflammasome activation and correlated with exosome release in murine macrophages. J. Immunol. 179:1913−1925. DOI:10.4049/jimmunol.179.3.1913 |
| [137] | Horibe S., Tanahashi T., Kawauchi S., et al. (2018). Mechanism of recipient cell-dependent differences in exosome uptake. BMC Cancer 18:47. DOI:10.1186/s12885-017-3958-1 |
| [138] | Smyth T. J., Redzic J. S., Graner M. W., et al. (2014). Examination of the specificity of tumor cell derived exosomes with tumor cells in vitro. Biochim. Biophys. Acta 1838:2954−2965. DOI:10.1016/j.bbamem.2014.07.026 |
| [139] | Charoenviriyakul C., Takahashi Y., Morishita M., et al. (2018). Role of extracellular vesicle surface proteins in the pharmacokinetics of extracellular vesicles. Mol. Pharm. 15:1073−1080. DOI:10.1021/acs.molpharmaceut.7b00950 |
| [140] | Nigri J., Leca J., Tubiana S. S., et al. (2022). CD9 mediates the uptake of extracellular vesicles from cancer-associated fibroblasts that promote pancreatic cancer cell aggressiveness. Sci. Signal 15:eabg8191. DOI:10.1126/scisignal.abg8191 |
| [141] | Chen Z., Yang L., Cui Y., et al. (2016). Cytoskeleton-centric protein transportation by exosomes transforms tumor-favorable macrophages. Oncotarget 7:67387−67402. DOI:10.18632/oncotarget.11794 |
| [142] | Hazawa M., Tomiyama K., Saotome-Nakamura A., et al. (2014). Radiation increases the cellular uptake of exosomes through CD29/CD81 complex formation. Biochem. Biophys. Res. Commun. 446:1165−1171. DOI:10.1016/j.bbrc.2014.03.067 |
| [143] | Jankovičová J., Sečová P., Michalková K., et al. (2020). Tetraspanins, more than markers of extracellular vesicles in reproduction. Int. J. Mol. Sci. 21:7568. DOI:10.3390/ijms21207568 |
| [144] | Irie N., Takada Y., Watanabe Y., et al. (2009). Bidirectional signaling through ephrinA2-EphA2 enhances osteoclastogenesis and suppresses osteoblastogenesis. J. Biol. Chem. 284:14637−14644. DOI:10.1074/jbc.M807598200 |
| [145] | Gong J., Körner R., Gaitanos L., et al. (2016). Exosomes mediate cell contact-independent ephrin-Eph signaling during axon guidance. J. Cell Biol. 214:35−44. DOI:10.1083/jcb.201601085 |
| [146] | Sato S., Vasaikar S., Eskaros A., et al. (2019). EPHB2 carried on small extracellular vesicles induces tumor angiogenesis via activation of ephrin reverse signaling. JCI Insight 4:e132447. DOI:10.1172/jci.insight.132447 |
| [147] | Kanno S., Hirano S., Sakamoto T., et al. (2020). Scavenger receptor MARCO contributes to cellular internalization of exosomes by dynamin-dependent endocytosis and macropinocytosis. Sci. Rep. 10:21795. DOI:10.1038/s41598-020-78464-2 |
| [148] | Williams C., Pazos R., Royo F., et al. (2019). Assessing the role of surface glycans of extracellular vesicles on cellular uptake. Sci. Rep. 9:11920. DOI:10.1038/s41598-019-48499-1 |
| [149] | Lin X. P., Mintern J. D. and Gleeson P. A. (2020). Macropinocytosis in different cell types: similarities and differences. Membranes (Basel) 10:177. DOI:10.3390/membranes10080177 |
| [150] | Feng D., Zhao W. L., Ye Y. Y., et al. (2010). Cellular internalization of exosomes occurs through phagocytosis. Traffic 11:675−687. DOI:10.1111/j.1600-0854.2010.01041.x |
| [151] | McKelvey K. J., Powell K. L., Ashton A. W., et al. (2015). Exosomes: mechanisms of uptake. J. Circ. Biomark 4:7. DOI:10.5772/61186 |
| [152] | Mulcahy L. A., Pink R. C. and Carter D. R. (2014). Routes and mechanisms of extracellular vesicle uptake. J. Extracell. Vesicles 3:24641. DOI:10.3402/jev.v3.24641 |
| [153] | Murphy D. E., de Jong O. G., Brouwer M., et al. (2019). Extracellular vesicle-based therapeutics: natural versus engineered targeting and trafficking. Exp Mol Med 51:1−12. DOI:10.1038/s12276-019-0223-5 |
| [154] | Gonda A., Kabagwira J., Senthil G. N., et al. (2018). Exosomal survivin facilitates vesicle internalization. Oncotarget 9:34919−34934. DOI:10.18632/oncotarget.26182 |
| [155] | Yao Z., Qiao Y., Li X., et al. (2018). Exosomes exploit the virus entry machinery and pathway to transmit alpha interferon-induced antiviral activity. J. Virol. 92:e01578−18. DOI:10.1128/jvi.01578-18 |
| [156] | Sandvig K., Torgersen M. L., Raa H. A., et al. (2008). Clathrin-independent endocytosis: from nonexisting to an extreme degree of complexity. Histochem. Cell Biol. 129:267−276. DOI:10.1007/s00418-007-0376-5 |
| [157] | Christianson H. C., Svensson K. J., van Kuppevelt T. H., et al. (2013). Cancer cell exosomes depend on cell-surface heparan sulfate proteoglycans for their internalization and functional activity. Proc. Natl. Acad. Sci. USA 110:17380−17385. DOI:10.1073/pnas.1304266110 |
| [158] | Fuentes P., Sesé M., Guijarro P. J., et al. (2020). ITGB3-mediated uptake of small extracellular vesicles facilitates intercellular communication in breast cancer cells. Nat. Commun. 11:4261. DOI:10.1038/s41467-020-18081-9 |
| [159] | Cerezo-Magaña M., Christianson H. C., van Kuppevelt T. H., et al. (2021). Hypoxic induction of exosome uptake through proteoglycan-dependent endocytosis fuels the lipid droplet phenotype in glioma. Mol. Cancer Res. 19:528−540. DOI:10.1158/1541-7786.Mcr-20-0560 |
| [160] | Fitzner D., Schnaars M., van Rossum D., et al. (2011). Selective transfer of exosomes from oligodendrocytes to microglia by macropinocytosis. J. Cell Sci. 124:447−458. DOI:10.1242/jcs.074088 |
| [161] | Nakase I., Kobayashi N. B., Takatani-Nakase T., et al. (2015). Active macropinocytosis induction by stimulation of epidermal growth factor receptor and oncogenic Ras expression potentiates cellular uptake efficacy of exosomes. Sci. Rep. 5:10300. DOI:10.1038/srep10300 |
| [162] | Svensson K. J., Christianson H. C., Wittrup A., et al. (2013). Exosome uptake depends on ERK1/2-heat shock protein 27 signaling and lipid Raft-mediated endocytosis negatively regulated by caveolin-1. J. Biol. Chem. 288:17713−17724. DOI:10.1074/jbc.M112.445403 |
| [163] | Tian T., Zhu Y. L., Zhou Y. Y., et al. (2014). Exosome uptake through clathrin-mediated endocytosis and macropinocytosis and mediating miR-21 delivery. J. Biol. Chem. 289:22258−22267. DOI:10.1074/jbc.M114.588046 |
| [164] | Heusermann W., Hean J., Trojer D., et al. (2016). Exosomes surf on filopodia to enter cells at endocytic hot spots, traffic within endosomes, and are targeted to the ER. J. Cell Biol. 213:173−184. DOI:10.1083/jcb.201506084 |
| [165] | O'Brien K., Ughetto S., Mahjoum S., et al. (2022). Uptake, functionality, and re-release of extracellular vesicle-encapsulated cargo. Cell Rep. 39:110651. DOI:10.1016/j.celrep.2022.110651 |
| [166] | Delenclos M., Trendafilova T., Mahesh D., et al. (2017). Investigation of endocytic pathways for the internalization of exosome-associated oligomeric alpha-synuclein. Front. Neurosci. 11:172. DOI:10.3389/fnins.2017.00172 |
| [167] | Szwed A., Kim E. and Jacinto E. (2021). Regulation and metabolic functions of mTORC1 and mTORC2. Physiol Rev 101:1371−1426. DOI:10.1152/physrev.00026.2020 |
| [168] | Wesselborg S. and Stork B. (2015). Autophagy signal transduction by ATG proteins: from hierarchies to networks. Cell Mol Life Sci. 72:4721−4757. DOI:10.1007/s00018-015-2034-8 |
| [169] | Puente C., Hendrickson R. C. and Jiang X. (2016). Nutrient-regulated phosphorylation of ATG13 inhibits starvation-induced autophagy. J. Biol. Chem. 291:6026−6035. DOI:10.1074/jbc.M115.689646 |
| [170] | Sini P., James D., Chresta C., et al. (2010). Simultaneous inhibition of mTORC1 and mTORC2 by mTOR kinase inhibitor AZD8055 induces autophagy and cell death in cancer cells. Autophagy 6:553−554. DOI:10.4161/auto.6.4.11671 |
| [171] | Liu X., Zhao P., Wang X., et al. (2019). Celastrol mediates autophagy and apoptosis via the ROS/JNK and Akt/mTOR signaling pathways in glioma cells. J. Exp. Clin. Cancer Res. 38:184. DOI:10.1186/s13046-019-1173-4 |
| [172] | Sarris E. G., Saif M. W. and Syrigos K. N. (2012). The biological role of PI3K pathway in lung cancer. Pharmaceuticals (Basel) 5:1236−1264. DOI:10.3390/ph5111236 |
| [173] | Guo S., Liang X., Guo M., et al. (2018). Migration inhibition of water stress proteins from Nostoc commune Vauch. via activation of autophagy in DLD-1 cells. Int. J. Biol. Macromol. 119:669-676. DOI:10.1016/j.ijbiomac.2018.07.188. |
| [174] | Sancak Y., Peterson T. R., Shaul Y. D., et al. (2008). The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science 320:1496−1501. DOI:10.1126/science.1157535 |
| [175] | Rabanal-Ruiz Y. and Korolchuk V. I. (2018). mTORC1 and nutrient homeostasis: the central role of the lysosome. Int. J. Mol. Sci. 19:818. DOI:10.3390/ijms19030818 |
| [176] | Zhang Z., Chen W. Q., Zhang S. Q., et al. (2022). Isoliquiritigenin inhibits pancreatic cancer progression through blockade of p38 MAPK-regulated autophagy. Phytomedicine 106:154406. DOI:10.1016/j.phymed.2022.154406 |
| [177] | Hardie D. G. (2015). AMPK: positive and negative regulation, and its role in whole-body energy homeostasis. Curr. Opin. Cell Biol. 33:1−7. DOI:10.1016/j.ceb.2014.09.004 |
| [178] | Castets P., Lin S., Rion N., et al. (2013). Sustained activation of mTORC1 in skeletal muscle inhibits constitutive and starvation-induced autophagy and causes a severe, late-onset myopathy. Cell Metab. 17:731−744. DOI:10.1016/j.cmet.2013.03.015 |
| [179] | Losier T. T. and Russell R. C. (2019). Bacterial outer membrane vesicles trigger pre-activation of a xenophagic response via AMPK. Autophagy 15:1489−1491. DOI:10.1080/15548627.2019.1618640 |
| [180] | Kim J., Kundu M., Viollet B., et al. (2011). AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat. Cell Biol. 13:132−141. DOI:10.1038/ncb2152 |
| [181] | Egan D. F., Shackelford D. B., Mihaylova M. M., et al. (2011). Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science 331:456−461. DOI:10.1126/science.1196371 |
| [182] | Liu Y., Su Z., Tavana O., et al. (2024). Understanding the complexity of p53 in a new era of tumor suppression. Cancer Cell 42:946−967. DOI:10.1016/j.ccell.2024.04.009 |
| [183] | Wirawan E., Lippens S., Vanden Berghe T., et al. (2012). Beclin1: a role in membrane dynamics and beyond. Autophagy 8:6−17. DOI:10.4161/auto.8.1.16645 |
| [184] | Feng Y., He D., Yao Z., et al. (2014). The machinery of macroautophagy. Cell Res. 24:24−41. DOI:10.1038/cr.2013.168 |
| [185] | Obara K. and Ohsumi Y. (2008). Dynamics and function of PtdIns(3)P in autophagy. Autophagy 4:952−954. DOI:10.4161/auto.6790 |
| [186] | Obara K., Noda T., Niimi K., et al. (2008). Transport of phosphatidylinositol 3-phosphate into the vacuole via autophagic membranes in Saccharomyces cerevisiae. Genes Cells 13:537−547. DOI:10.1111/j.1365-2443.2008.01188.x |
| [187] | Maejima Y., Isobe M. and Sadoshima J. (2016). Regulation of autophagy by Beclin 1 in the heart. J. Mol. Cell Cardiol. 95:19−25. DOI:10.1016/j.yjmcc.2015.10.032 |
| [188] | Kang R., Zeh H. J., Lotze M. T., et al. (2011). The Beclin 1 network regulates autophagy and apoptosis. Cell Death Differ. 18:571−580. DOI:10.1038/cdd.2010.191 |
| [189] | Hariharan N., Maejima Y., Nakae J., et al. (2010). Deacetylation of FoxO by sirt1 plays an essential role in mediating starvation-induced autophagy in cardiac myocytes. Circ. Res. 107:1470−1482. DOI:10.1161/circresaha.110.227371 |
| [190] | Cheng Z. (2019). The FoxO-Autophagy axis in health and disease. Trends Endocrinol. Metab. 30:658−671. DOI:10.1016/j.tem.2019.07.009 |
| [191] | Xiong X., Tao R., DePinho R. A., et al. (2012). The autophagy-related gene 14 (Atg14) is regulated by forkhead box O transcription factors and circadian rhythms and plays a critical role in hepatic autophagy and lipid metabolism. J. Biol. Chem. 287:39107−39114. DOI:10.1074/jbc.M112.412569 |
| [192] | Chen Y., Lv L., Pi H., et al. (2016). Dihydromyricetin protects against liver ischemia/reperfusion induced apoptosis via activation of FOXO3a-mediated autophagy. Oncotarget 7:76508−76522. DOI:10.18632/oncotarget.12894 |
| [193] | Choi S., Jeong H. J., Kim H., et al. (2019). Skeletal muscle-specific Prmt1 deletion causes muscle atrophy via deregulation of the PRMT6-FOXO3 axis. Autophagy 15:1069−1081. DOI:10.1080/15548627.2019.1569931 |
| [194] | Liu L., Tao Z., Zheng L. D., et al. (2016). FoxO1 interacts with transcription factor EB and differentially regulates mitochondrial uncoupling proteins via autophagy in adipocytes. Cell Death Discov. 2:16066. DOI:10.1038/cddiscovery.2016.66 |
| [195] | Füllgrabe J., Klionsky D. J. and Joseph B. (2014). The return of the nucleus: transcriptional and epigenetic control of autophagy. Nat. Rev. Mol. Cell Biol. 15:65−74. DOI:10.1038/nrm3716 |
| [196] | O'Neill B. T., Bhardwaj G., Penniman C. M., et al. (2019). FoxO transcription factors are critical regulators of diabetes-related muscle atrophy. Diabetes 68:556−570. DOI:10.2337/db18-0416 |
| [197] | Li L., Zviti R., Ha C., et al. (2017). Forkhead box O3 (FoxO3) regulates kidney tubular autophagy following urinary tract obstruction. J. Biol. Chem. 292:13774−13783. DOI:10.1074/jbc.M117.791483 |
| [198] | Wang S., Xia P., Huang G., et al. (2016). FoxO1-mediated autophagy is required for NK cell development and innate immunity. Nat. Commun. 7:11023. DOI:10.1038/ncomms11023 |
| [199] | Zhao Y., Yang J., Liao W., et al. (2010). Cytosolic FoxO1 is essential for the induction of autophagy and tumour suppressor activity. Nat. Cell Biol. 12:665−675. DOI:10.1038/ncb2069 |
| [200] | He W., Zhang A., Qi L., et al. (2018). FOXO1, a potential therapeutic target, regulates autophagic flux, oxidative stress, mitochondrial dysfunction, and apoptosis in human cholangiocarcinoma QBC939 cells. Cell Physiol Biochem 45:1506−1514. DOI:10.1159/000487576 |
| [201] | Kishino A., Hayashi K., Hidai C., et al. (2017). XBP1-FoxO1 interaction regulates ER stress-induced autophagy in auditory cells. Sci. Rep. 7:4442. DOI:10.1038/s41598-017-02960-1 |
| [202] | Martino D., Neeland M., Dang T., et al. (2018). Epigenetic dysregulation of naive CD4+ T-cell activation genes in childhood food allergy. Nat. Commun. 9:3308. DOI:10.1038/s41467-018-05608-4 |
| [203] | Hargarten J. C. and Williamson P. R. (2018). Epigenetic regulation of autophagy: a path to the control of autoimmunity. Front. Immunol. 9:1864. DOI:10.3389/fimmu.2018.01864 |
| [204] | Lapierre L. R., Kumsta C., Sandri M., et al. (2015). Transcriptional and epigenetic regulation of autophagy in aging. Autophagy 11:867−880. DOI:10.1080/15548627.2015.1034410 |
| [205] | Fitzwalter B. E., Towers C. G., Sullivan K. D., et al. (2018). Autophagy inhibition mediates apoptosis sensitization in cancer therapy by relieving FOXO3a turnover. Dev. Cell 44:555−565.e553. DOI:10.1016/j.devcel.2018.02.014 |
| [206] | Toledo M., Batista-Gonzalez A., Merheb E., et al. (2018). Autophagy regulates the liver clock and glucose metabolism by degrading CRY1. Cell Metab. 28:268−281.e4. DOI:10.1016/j.cmet.2018.05.023 |
| [207] | Nivon M., Abou-Samra M., Richet E., et al. (2012). NF-κB regulates protein quality control after heat stress through modulation of the BAG3-HspB8 complex. J. Cell Sci. 125:1141−1151. DOI:10.1242/jcs.091041 |
| [208] | Yan Y., Chen X., Huang J., et al. (2022). H2O2-induced oxidative stress impairs meat quality by inducing apoptosis and autophagy via ROS/NF-κB signaling pathway in broiler thigh muscle. Poult. Sci. 101:101759. DOI:10.1016/j.psj.2022.101759 |
| [209] | Rapino F., Abhari B. A., Jung M., et al. (2015). NIK is required for NF-κB-mediated induction of BAG3 upon inhibition of constitutive protein degradation pathways. Cell Death Dis 6:e1692. DOI:10.1038/cddis.2014.584 |
| [210] | Balaburski G. M., Hontz R. D. and Murphy M. E. (2010). p53 and ARF: unexpected players in autophagy. Trends Cell Biol. 20:363−369. DOI:10.1016/j.tcb.2010.02.007 |
| [211] | Morgan M. J. and Liu Z. G. (2011). Crosstalk of reactive oxygen species and NF-κB signaling. Cell Res. 21:103−115. DOI:10.1038/cr.2010.178 |
| [212] | Salminen A., Ojala J., Kaarniranta K., et al. (2012). Mitochondrial dysfunction and oxidative stress activate inflammasomes: impact on the aging process and age-related diseases. Cell Mol. Life Sci. 69:2999−3013. DOI:10.1007/s00018-012-0962-0 |
| [213] | Xu Y., Jagannath C., Liu X. D., et al. (2007). Toll-like receptor 4 is a sensor for autophagy associated with innate immunity. Immunity 27:135−144. DOI:10.1016/j.immuni.2007.05.022 |
| [214] | Delgado M. A., Elmaoued R. A., Davis A. S., et al. (2008). Toll-like receptors control autophagy. Embo J. 27:1110−1121. DOI:10.1038/emboj.2008.31 |
| [215] | Duan T., Du Y., Xing C., et al. (2022). Toll-like receptor signaling and its role in cell-mediated immunity. Front. Immunol. 13:812774. DOI:10.3389/fimmu.2022.812774 |
| [216] | Into T., Inomata M., Takayama E., et al. (2012). Autophagy in regulation of Toll-like receptor signaling. Cell Signal 24:1150−1162. DOI:10.1016/j.cellsig.2012.01.020 |
| [217] | Verzella D., Pescatore A., Capece D., et al. (2020). Life, death, and autophagy in cancer: NF-κB turns up everywhere. Cell Death Dis. 11:210. DOI:10.1038/s41419-020-2399-y |
| [218] | Lee J. W., Nam H., Kim L. E., et al. (2019). TLR4 (toll-like receptor 4) activation suppresses autophagy through inhibition of FOXO3 and impairs phagocytic capacity of microglia. Autophagy 15:753−770. DOI:10.1080/15548627.2018.1556946 |
| [219] | De Meyer I., Martinet W., Schrijvers D. M., et al. (2012). Toll-like receptor 7 stimulation by imiquimod induces macrophage autophagy and inflammation in atherosclerotic plaques. Basic Res. Cardiol. 107:269. DOI:10.1007/s00395-012-0269-1 |
| [220] | de Abreu R. C., Fernandes H., da Costa Martins P. A., et al. (2020). Native and bioengineered extracellular vesicles for cardiovascular therapeutics. Nat. Rev. Cardiol. 17:685−697. DOI:10.1038/s41569-020-0389-5 |
| [221] | Wang X., Huang J., Chen W., et al. (2022). The updated role of exosomal proteins in the diagnosis, prognosis, and treatment of cancer. Exp. Mol. Med. 54:1390−1400. DOI:10.1038/s12276-022-00855-4 |
| [222] | Guo L., Quan M., Pang W., et al. (2023). Cytokines and exosomal miRNAs in skeletal muscle-adipose crosstalk. Trends Endocrinol. Metab. 34:666−681. DOI:10.1016/j.tem.2023.07.006 |
| [223] | Fanzani A., Conraads V. M., Penna F., et al. (2012). Molecular and cellular mechanisms of skeletal muscle atrophy: an update. J. Cachexia Sarcopenia Muscle 3:163−179. DOI:10.1007/s13539-012-0074-6 |
| [224] | Bonaldo P. and Sandri M. (2013). Cellular and molecular mechanisms of muscle atrophy. Dis. Model Mech. 6:25−39. DOI:10.1242/dmm.010389 |
| [225] | Singh A., Yadav A., Phogat J., et al. (2022). Dynamics and interplay between autophagy and ubiquitin-proteasome system coordination in skeletal muscle atrophy. Curr. Mol. Pharmacol. 15:475−486. DOI:10.2174/1874467214666210806163851 |
| [226] | Argilés J. M., Busquets S. and López-Soriano F. J. (2003). Cytokines in the pathogenesis of cancer cachexia. Curr. Opin. Clin. Nutr. Metab. Care 6:401−406. DOI:10.1097/01.mco.0000078983.18774.cc |
| [227] | Fearon K. C., Glass D. J. and Guttridge D. C. (2012). Cancer cachexia: mediators, signaling, and metabolic pathways. Cell Metab. 16:153−166. DOI:10.1016/j.cmet.2012.06.011 |
| [228] | Argilés J. M. and López-Soriano F. J. (1999). The role of cytokines in cancer cachexia. Med. Res. Rev. 19:223−248. DOI:3.0.co;2-n">10.1002/(sici)1098-1128(199905)19:3<223::aid-med3>3.0.co;2-n |
| [229] | Zhang X., Zhao Y. and Yan W. (2023). The role of extracellular vesicles in skeletal muscle wasting. J. Cachexia Sarcopenia Muscle 14:2462−2472. DOI:10.1002/jcsm.13364 |
| [230] | Yan W., Cao M., Ruan X., et al. (2022). Cancer-cell-secreted miR-122 suppresses O-GlcNAcylation to promote skeletal muscle proteolysis. Nat. Cell Biol. 24:793−804. DOI:10.1038/s41556-022-00893-0 |
| [231] | Waning D. L., Mohammad K. S., Reiken S., et al. (2015). Excess TGF-β mediates muscle weakness associated with bone metastases in mice. Nat. Med. 21:1262−1271. DOI:10.1038/nm.3961 |
| [232] | Miao C., Zhang W., Feng L., et al. (2021). Cancer-derived exosome miRNAs induce skeletal muscle wasting by Bcl-2-mediated apoptosis in colon cancer cachexia. Mol. Ther. Nucleic Acids 24:923−938. DOI:10.1016/j.omtn.2021.04.015 |
| [233] | He W. A., Calore F., Londhe P., et al. (2014). Microvesicles containing miRNAs promote muscle cell death in cancer cachexia via TLR7. Proc. Natl. Acad. Sci. USA 111:4525−4529. DOI:10.1073/pnas.1402714111 |
| [234] | Kuang J. X., Shen Q., Zhang R. Q., et al. (2022). Carnosol attenuated atrophy of C2C12 myotubes induced by tumour-derived exosomal miR-183-5p through inhibiting Smad3 pathway activation and keeping mitochondrial respiration. Basic Clin. Pharmacol. Toxicol. 131:500−513. DOI:10.1111/bcpt.13795 |
| [235] | Li Z., Liu C., Li S., et al. (2021). BMSC-derived exosomes inhibit dexamethasone-induced muscle atrophy via the miR-486-5p/FoxO1 Axis. Front Endocrinol (Lausanne) 12:681267. DOI:10.3389/fendo.2021.681267 |
| [236] | Zhang G., Liu Z., Ding H., et al. (2017). Tumor induces muscle wasting in mice through releasing extracellular Hsp70 and Hsp90. Nat. Commun. 8:589. DOI:10.1038/s41467-017-00726-x |
| [237] | Yang J., Zhang Z., Zhang Y., et al. (2019). ZIP4 promotes muscle wasting and cachexia in mice with orthotopic pancreatic tumors by stimulating rab27b-regulated release of extracellular vesicles from cancer cells. Gastroenterology 156:722−734.e6. DOI:10.1053/j.gastro.2018.10.026 |
| [238] | Li L., Liu H., Tao W., et al. (2021). Pharmacological inhibition of HMGB1 prevents muscle wasting. Front. Pharmacol. 12:731386. DOI:10.3389/fphar.2021.731386 |
| [239] | Shin E., Kang H., Lee H., et al. (2022). Exosomal plasminogen activator inhibitor-1 induces ionizing radiation-adaptive glioblastoma cachexia. Cells 11:3102. DOI:10.3390/cells11193102 |
| [240] | You L., Wang Z., Li H., et al. (2015). The role of STAT3 in autophagy. Autophagy 11:729−739. DOI:10.1080/15548627.2015.1017192 |
| [241] | Strassmann G., Fong M., Kenney J. S., et al. (1992). Evidence for the involvement of interleukin 6 in experimental cancer cachexia. J. Clin. Invest. 89:1681−1684. DOI:10.1172/jci115767 |
| [242] | Narsale A. A. and Carson J. A. (2014). Role of interleukin-6 in cachexia: therapeutic implications. Curr. Opin. Support Palliat. Care 8:321−327. DOI:10.1097/spc.0000000000000091 |
| [243] | Haddad F., Zaldivar F., Cooper D. M., et al. (2005). IL-6-induced skeletal muscle atrophy. J. Appl. Physiol. (1985) 98:911-917. DOI:10.1152/japplphysiol.01026.2004. |
| [244] | Hu W., Ru Z., Zhou Y., et al. (2019). Lung cancer-derived extracellular vesicles induced myotube atrophy and adipocyte lipolysis via the extracellular IL-6-mediated STAT3 pathway. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1864:1091−1102. DOI:10.1016/j.bbalip.2019.04.006 |
| [245] | Zhang W., Sun W., Gu X., et al. (2022). GDF-15 in tumor-derived exosomes promotes muscle atrophy via Bcl-2/caspase-3 pathway. Cell Death Discov. 8:162. DOI:10.1038/s41420-022-00972-z |
| [246] | Fauré J., Lachenal G., Court M., et al. (2006). Exosomes are released by cultured cortical neurones. Mol. Cell Neurosci. 31:642−648. DOI:10.1016/j.mcn.2005.12.003 |
| [247] | Popov V. I., Medvedev N. I., Kraev I. V., et al. (2008). A cell adhesion molecule mimetic, FGL peptide, induces alterations in synapse and dendritic spine structure in the dentate gyrus of aged rats: a three-dimensional ultrastructural study. Eur. J. Neurosci. 27:301−314. DOI:10.1111/j.1460-9568.2007.06004.x |
| [248] | Putz U., Howitt J., Lackovic J., et al. (2008). Nedd4 family-interacting protein 1 (Ndfip1) is required for the exosomal secretion of Nedd4 family proteins. J. Biol. Chem. 283:32621−32627. DOI:10.1074/jbc.M804120200 |
| [249] | Lee M., Ban J. J., Yang S., et al. (2018). The exosome of adipose-derived stem cells reduces β-amyloid pathology and apoptosis of neuronal cells derived from the transgenic mouse model of Alzheimer's disease. Brain Res. 1691:87−93. DOI:10.1016/j.brainres.2018.03.034 |
| [250] | Jiang Y., Xie H., Tu W., et al. (2018). Exosomes secreted by HUVECs attenuate hypoxia/reoxygenation-induced apoptosis in neural cells by suppressing miR-21-3p. Am. J. Transl. Res. 10:3529−3541. |
| [251] | Jiang M., Wang H., Jin M., et al. (2018). Exosomes from miR-30d-5p-ADSCs reverse acute ischemic stroke-induced, autophagy-mediated brain injury by promoting M2 microglial/macrophage polarization. Cell Physiol. Biochem. 47:864−878. DOI:10.1159/000490078 |
| [252] | Chen H. X., Liang F. C., Gu P., et al. (2020). Exosomes derived from mesenchymal stem cells repair a Parkinson's disease model by inducing autophagy. Cell Death Dis. 11:288. DOI:10.1038/s41419-020-2473-5 |
| [253] | Rong Y., Liu W., Wang J., et al. (2019). Neural stem cell-derived small extracellular vesicles attenuate apoptosis and neuroinflammation after traumatic spinal cord injury by activating autophagy. Cell Death Dis. 10:340. DOI:10.1038/s41419-019-1571-8 |
| [254] | Wu X., Liu Z., Yu X. Y., et al. (2021). Autophagy and cardiac diseases: Therapeutic potential of natural products. Med. Res. Rev. 41:314−341. DOI:10.1002/med.21733 |
| [255] | Yang Y., Li Y., Chen X., et al. (2016). Exosomal transfer of miR-30a between cardiomyocytes regulates autophagy after hypoxia. J. Mol. Med. 94:711−724. DOI:10.1007/s00109-016-1387-2 |
| [256] | Wang Y., Hao Y., Zhang H., et al. (2020). DNA hypomethylation of miR-30a mediated the protection of hypoxia postconditioning against aged cardiomyocytes hypoxia/reoxygenation injury through inhibiting autophagy. Circ. J. 84:616−625. DOI:10.1253/circj.CJ-19-0915 |
| [257] | Wang W., Peng X., Zhao L., et al. (2023). Extracellular vesicles from bone marrow mesenchymal stem cells inhibit apoptosis and autophagy of ischemia-hypoxia cardiomyocyte line in vitro by carrying miR-144-3p to inhibit ROCK1. Curr. Stem Cell Res. Ther. 18:247−259. DOI:10.2174/1574888x17666220503192941 |
| [258] | Li L., Wang Z., Hu X., et al. (2016). Human aortic smooth muscle cell-derived exosomal miR-221/222 inhibits autophagy via a PTEN/Akt signaling pathway in human umbilical vein endothelial cells. Biochem. Biophys. Res. Commun. 479:343−350. DOI:10.1016/j.bbrc.2016.09.078 |
| [259] | Li Y., Yang R., Guo B., et al. (2019). Exosomal miR-301 derived from mesenchymal stem cells protects myocardial infarction by inhibiting myocardial autophagy. Biochem. Biophys. Res. Commun. 514:323−328. DOI:10.1016/j.bbrc.2019.04.138 |
| [260] | Ke X., Liao Z., Luo X., et al. (2022). Endothelial colony-forming cell-derived exosomal miR-21-5p regulates autophagic flux to promote vascular endothelial repair by inhibiting SIPL1A2 in atherosclerosis. Cell Commun. Signal 20:30. DOI:10.1186/s12964-022-00828-0 |
| [261] | Li T., Gu J., Yang O., et al. (2020). Bone marrow mesenchymal stem cell-derived exosomal miRNA-29c decreases cardiac ischemia/reperfusion injury through inhibition of excessive autophagy via the PTEN/Akt/mTOR signaling pathway. Circ. J. 84:1304−1311. DOI:10.1253/circj.CJ-19-1060 |
| [262] | Xiao C., Wang K., Xu Y., et al. (2018). Transplanted mesenchymal stem cells reduce autophagic flux in infarcted hearts via the exosomal transfer of miR-125b. Circ Res 123:564−578. DOI:10.1161/circresaha.118.312758 |
| [263] | Gong X. H., Liu H., Wang S. J., et al. (2019). Exosomes derived from SDF1-overexpressing mesenchymal stem cells inhibit ischemic myocardial cell apoptosis and promote cardiac endothelial microvascular regeneration in mice with myocardial infarction. J. Cell Physiol. 234:13878−13893. DOI:10.1002/jcp.28070 |
| [264] | Zhao S., Liu Y. and Pu Z. (2019). Bone marrow mesenchymal stem cell-derived exosomes attenuate D-GaIN/LPS-induced hepatocyte apoptosis by activating autophagy in vitro. Drug Des. Devel. Ther. 13:2887−2897. DOI:10.2147/dddt.S220190 |
| [265] | Lin D., Chen H., Xiong J., et al. (2022). Mesenchymal stem cells exosomal let-7a-5p improve autophagic flux and alleviate liver injury in acute-on-chronic liver failure by promoting nuclear expression of TFEB. Cell Death Dis. 13:865. DOI:10.1038/s4141 |
| [266] | Yang B., Duan W., Wei L., et al. (2020). Bone marrow mesenchymal stem cell-derived hepatocyte-like cell exosomes reduce hepatic ischemia/reperfusion injury by enhancing autophagy. Stem Cells Dev. 29:372−379. DOI:10.1089/scd.2019.0194 |
| [267] | Qu Y., Zhang Q., Cai X., et al. (2017). Exosomes derived from miR-181-5p-modified adipose-derived mesenchymal stem cells prevent liver fibrosis via autophagy activation. J. Cell Mol. Med. 21:2491−2502. DOI:10.1111/jcmm.13170 |
| [268] | Zhang L., Song Y., Chen L., et al. (2020). MiR-20a-containing exosomes from umbilical cord mesenchymal stem cells alleviates liver ischemia/reperfusion injury. J. Cell Physiol. 235:3698−3710. DOI:10.1002/jcp.29264 |
| [269] | Wang X., Dong F. L., Wang Y. Q., et al. (2023). Exosomal circTGFBR2 promotes hepatocellular carcinoma progression via enhancing ATG5 mediated protective autophagy. Cell Death Dis. 14:451. DOI:10.1038/s41419-023-05989-5 |
| [270] | Chen H., Liu J., Peng S., et al. (2023). Autophagy and exosomes coordinately mediate quercetin's protective effects on alcoholic liver disease. J. Nutr. Biochem. 116:109332. DOI:10.1016/j.jnutbio.2023.109332 |
| [271] | Ebaid H., Bashandy S. A. E., Abdel-Mageed A. M., et al. (2020). Folic acid and melatonin mitigate diabetic nephropathy in rats via inhibition of oxidative stress. Nutr. Metab. 17:6. DOI:10.1186/s12986-019-0419-7 |
| [272] | Siddhi J., Sherkhane B., Kalavala A. K., et al. (2022). Melatonin prevents diabetes-induced nephropathy by modulating the AMPK/SIRT1 axis: Focus on autophagy and mitochondrial dysfunction. Cell Biol. Int. 46:2142−2157. DOI:10.1002/cbin.11899 |
| [273] | Dong W., Zhang H., Zhao C., et al. (2021). Silencing of miR-150-5p ameliorates diabetic nephropathy by targeting SIRT1/p53/AMPK pathway. Front. Physiol. 12:624989. DOI:10.3389/fphys.2021.624989 |
| [274] | Ebrahim N., Ahmed I. A., Hussien N. I., et al. (2018). Mesenchymal stem cell-derived exosomes ameliorated diabetic nephropathy by autophagy induction through the mTOR signaling pathway. Cells 7:226. DOI:10.3390/cells7120226 |
| [275] | Jin J., Shi Y., Gong J., et al. (2019). Exosome secreted from adipose-derived stem cells attenuates diabetic nephropathy by promoting autophagy flux and inhibiting apoptosis in podocyte. Stem Cell Res. Ther. 10:95. DOI:10.1186/s13287-019-1177-1 |
| [276] | Wang J., Jia H., Zhang B., et al. (2018). HucMSC exosome-transported 14-3-3ζ prevents the injury of cisplatin to HK-2 cells by inducing autophagy in vitro. Cytotherapy 20:29−44. DOI:10.1016/j.jcyt.2017.08.002 |
| [277] | Jia H., Liu W., Zhang B., et al. (2018). HucMSC exosomes-delivered 14-3-3ζ enhanced autophagy via modulation of ATG16L in preventing cisplatin-induced acute kidney injury. Am. J. Transl. Res. 10:101−113. |
| [278] | Wang B., Jia H., Zhang B., et al. (2017). Pre-incubation with hucMSC-exosomes prevents cisplatin-induced nephrotoxicity by activating autophagy. Stem Cell Res. Ther. 8:75. DOI:10.1186/s13287-016-0463-4 |
| [279] | Jin C., Cao Y. and Li Y. (2023). Bone mesenchymal stem cells origin exosomes are effective against sepsis-induced acute kidney injury in rat model. Int. J. Nanomedicine 18:7745−7758. DOI:10.2147/ijn.S417627 |
| [280] | Yuan Y., Yuan L., Yang J., et al. (2024). Autophagy-deficient macrophages exacerbate cisplatin-induced mitochondrial dysfunction and kidney injury via miR-195a-5p-SIRT3 axis. Nat. Commun. 15:4383. DOI:10.1038/s41467-024-47842-z |
| [281] | Dey B. K., Gagan J., Yan Z., et al. (2012). MiR-26a is required for skeletal muscle differentiation and regeneration in mice. Genes Dev. 26:2180−2191. DOI:10.1101/gad.198085.112 |
| [282] | Wang B., Zhang A., Wang H., et al. (2019). MiR-26a limits muscle wasting and cardiac fibrosis through exosome-mediated microrna transfer in chronic kidney disease. Theranostics 9:1864−1877. DOI:10.7150/thno.29579 |
| [283] | Barone R., Macaluso F., Sangiorgi C., et al. (2016). Skeletal muscle heat shock protein 60 increases after endurance training and induces peroxisome proliferator-activated receptor gamma coactivator 1 α1 expression. Sci. Rep. 6:19781. DOI:10.1038/srep19781 |
| [284] | Di Felice V., Barone R., Trovato E., et al. (2022). Physiactisome: a new nanovesicle drug containing heat shock protein 60 for treating muscle wasting and cachexia. Cells 11:1406. DOI:10.3390/cells11091406 |
| [285] | Conceição M., Forcina L., Wiklander O. P. B., et al. (2021). Engineered extracellular vesicle decoy receptor-mediated modulation of the IL6 trans-signalling pathway in muscle. Biomaterials 266:120435. DOI:10.1016/j.biomaterials.2020.120435 |
| [286] | Iyaswamy A., Thakur A., Guan X. J., et al. (2023). Fe65-engineered neuronal exosomes encapsulating corynoxine-B ameliorate cognition and pathology of Alzheimer's disease. Signal Transduct. Target Ther. 8:404. DOI:10.1038/s41392-023-01657-4 |
| [287] | Xu F., Wu Y., Yang Q., et al. (2022). Engineered extracellular vesicles with SHP2 high expression promote mitophagy for Alzheimer's disease treatment. Adv. Mater. 34:e2207107. DOI:10.1002/adma.202207107 |
| [288] | Zhu X., Liu Q., Zhu F., et al. (2024). An engineered cellular carrier delivers miR-138-5p to enhance mitophagy and protect hypoxic-injured neurons via the DNMT3A/Rhebl1 axis. Acta Biomater. 186:424−438. DOI:10.1016/j.actbio.2024.07.059 |
| [289] | Sul J. H., Shin S., Kim H. K., et al. (2024). Dopamine-conjugated extracellular vesicles induce autophagy in Parkinson's disease. J. Extracell. Vesicles 13:e70018. DOI:10.1002/jev2.70018 |
| [290] | Wu J., Wu J., Xiang W., et al. (2024). Engineering exosomes derived from TNF-α preconditioned IPFP-MSCs enhance both yield and therapeutic efficacy for osteoarthritis. J. Nanobiotechnology 22:555. DOI:10.1186/s12951-024-02795-9 |
| [291] | Chen M., Liu Y., Liu Q., et al. (2025). Nanoengineered cargo with targeted in vivo Foxo3 gene editing modulated mitophagy of chondrocytes to alleviate osteoarthritis. Acta Pharm. Sin. B 15:571−591. DOI:10.1016/j.apsb.2024.12.008 |
| [292] | Liu D. A., Tao K., Wu B., et al. (2023). A phosphoinositide switch mediates exocyst recruitment to multivesicular endosomes for exosome secretion. Nat. Commun. 14:6883. DOI:10.1038/s41467-023-42661-0 |
| [293] | Domingues N., Pires J., Milosevic I., et al. (2024). Role of lipids in interorganelle communication. Trends Cell Biol. DOI:10.1016/j.tcb.2024.04.008. |
| [294] | Chung J., Park J., Lai Z. W., et al. (2023). The troyer syndrome protein spartin mediates selective autophagy of lipid droplets. Nat. Cell Biol. 25:1101−1110. DOI:10.1038/s41556-023-01178-w |
| [295] | Pu M., Zheng W., Zhang H., et al. (2023). ORP8 acts as a lipophagy receptor to mediate lipid droplet turnover. Protein Cell 14:653−667. DOI:10.1093/procel/pwac063 |
| [296] | Yuan Z., Cai K., Li J., et al. (2024). ATG14 targets lipid droplets and acts as an autophagic receptor for syntaxin18-regulated lipid droplet turnover. Nat. Commun. 15:631. DOI:10.1038/s41467-024-44978-w |
| Li Q., Chen S., Yin Y., et al. (2025). Intracellular and intercellular crosstalk between exosomes and autophagy. The Innovation Life 3:100132. https://doi.org/10.59717/j.xinn-life.2025.100132 |
To request copyright permission to republish or share portions of our works, please visit Copyright Clearance Center's (CCC) Marketplace website at marketplace.copyright.com.
Classical and non-classical exosome biogenesis
Three categories of autophagy
The intracellular intersection of exosome biogenesis and autophagy
Autophagy-related signals
Exosomal cargoes regulate autophagy-related diseases